|
Pathology | Model | Origin | Administration | Therapeutic effect | Reference |
|
Cancer | BALB/c mice Syngeneic breast cancer model | Murine BMSCs-exosomes | 2 × 105 4T1 cells mixed with 100 or 200 μg exosomes | ↓ expression of VEGF in tumor breast cells ↓ angiogenesis in vitro and in vivo ↓ tumor growth in vivo | [15] |
|
Cancer | BALB/c nu/nu mice Xenogeneic gastric cancer model | BMSCs-exosomes | 1 × 106 SGC-7901 cells mixed with 200 μg exosomes | ↑ expression of VEGF in tumor breast cells ↑ angiogenesis in vitro and in vivo ↑ tumor growth in vivo | [17] |
|
Wound healing | Cutaneous wound model in streptozotocin-induced diabetic rat | LPS-preconditioned UC-MSCs-exosomes | 60 exosomes, injected into the wound edge | ↓ inflammatory cell infiltration ↑ angiogenesis ↑ cutaneous wound healing | [46] |
|
Stroke | Wistar rats Middle cerebral artery occlusion | Rat BMSCs-exosomes | 100 μg exosomes, intravenous | ↑ neurite remodeling ↑ neurogenesis ↑ angiogenesis | [47] |
|
Brain injury | Wistar rats Traumatic brain injury | Rat MSCs-exosomes | 100 μg exosomes, intravenous | ↑ angiogenesis ↑ neurogenesis ↓ inflammation | [48] |
|
CVD | Wistar rats Acute myocardial infarction | Human BM-MSCs EVs | 80 μg EVs, intramyocardial injection | ↑ angiogenesis ↑ migration ↓ infarct size ↑ cardiac function | [49] |
|
CVD | Sprague-Dawley rats Myocardial infarction | Rat BM-MSCs-exosomes | 80 μg exosomes, intramyocardial injection | ↑ angiogenesis ↓ inflammation ↓ infarct size ↑ cardiac function | [50] |
|
CVD | Sprague-Dawley rats Acute myocardial infarction | Human UC-MSCs-exosomes | 400 μg exosomes, intravenous | ↑ angiogenesis ↑ migration ↓ apoptosis ↓ cardiac fibrosis ↓ infarct size ↑ cardiac function | [51] |
|
CVD | Sprague-Dawley rats Myocardial infarction | Rat BM-MSCs overexpressed CXCR4 exosomes | Not specified | ↑ angiogenesis ↓ infarct size ↑ cardiac function | [18] |
|